Matches in Nanopublications for { ?s ?p "[Systematic research at University of Arkansas over the last 10 years, has revealed that the absence of unfavorable cytogenetic abnormalities (deletion of chromosome 13 and hypodiploidy), low beta-2 microglobulin levels prior to transplant, a normal lactate dehydrogenase level at diagnosis and early application of high-dose treatment (< 12 months of preceding standard treatment) define a subgroup of myeloma patients with a high likelihood of long (> 5 years) event-free survival; a sizable minority of these patients may be considered cured.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 2 of
2
with 100 items per page.
- NP540172.RAz25ZigW8Q8EZXBoIpUoc2-4oRHU7Tn9AtPWWxNTK7_Y130_assertion description "[Systematic research at University of Arkansas over the last 10 years, has revealed that the absence of unfavorable cytogenetic abnormalities (deletion of chromosome 13 and hypodiploidy), low beta-2 microglobulin levels prior to transplant, a normal lactate dehydrogenase level at diagnosis and early application of high-dose treatment (< 12 months of preceding standard treatment) define a subgroup of myeloma patients with a high likelihood of long (> 5 years) event-free survival; a sizable minority of these patients may be considered cured.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP540172.RAz25ZigW8Q8EZXBoIpUoc2-4oRHU7Tn9AtPWWxNTK7_Y130_provenance.
- NP291074.RAIJxlESMwGQ_Vesmxv1t_QsPF1t7eh9Wo7Yie_IPHmPg130_assertion description "[Systematic research at University of Arkansas over the last 10 years, has revealed that the absence of unfavorable cytogenetic abnormalities (deletion of chromosome 13 and hypodiploidy), low beta-2 microglobulin levels prior to transplant, a normal lactate dehydrogenase level at diagnosis and early application of high-dose treatment (< 12 months of preceding standard treatment) define a subgroup of myeloma patients with a high likelihood of long (> 5 years) event-free survival; a sizable minority of these patients may be considered cured.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP291074.RAIJxlESMwGQ_Vesmxv1t_QsPF1t7eh9Wo7Yie_IPHmPg130_provenance.